{"id":377257,"date":"2025-09-23T18:11:09","date_gmt":"2025-09-23T18:11:09","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-omeros-corporation\/"},"modified":"2025-09-23T18:11:09","modified_gmt":"2025-09-23T18:11:09","slug":"how-to-buy-omeros-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/","title":{"rendered":"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-377257","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r - Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r - Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131"},"description":"Omeros Corporation (OMER) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131, g\u00fcncel fiyat analizini, 2025-2030 tahminlerini ve biyoteknoloji hisse senedi f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejisini \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Omeros Corporation (OMER) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131, g\u00fcncel fiyat analizini, 2025-2030 tahminlerini ve biyoteknoloji hisse senedi f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejisini \u00f6\u011frenin."},"intro":"Portf\u00f6y\u00fcn\u00fcze umut vadeden bir biyoteknoloji \u015firketi eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Omeros Corporation (OMER), yenilik\u00e7i \u00fcr\u00fcn hatt\u0131 ve son finansal iyile\u015fmeleriyle ila\u00e7 sekt\u00f6r\u00fcnde ilgi \u00e7ekici bir f\u0131rsat sunuyor. Klinik a\u015famadaki bir biyofarmas\u00f6tik \u015firketi olarak Omeros, yat\u0131r\u0131mc\u0131lara tamamlay\u0131c\u0131 arac\u0131l\u0131 hastal\u0131klar ve merkezi sinir sistemi bozukluklar\u0131 i\u00e7in son teknoloji tedavilere eri\u015fim imkan\u0131 sa\u011fl\u0131yor. Bu volatil ancak potansiyel olarak kazan\u00e7l\u0131 yat\u0131r\u0131m i\u00e7in mevcut hisse performans\u0131ndan ak\u0131ll\u0131 giri\u015f stratejilerine kadar her \u015feyi inceleyece\u011fiz.","intro_source":{"label":"Intro","type":"text","formatted_value":"Portf\u00f6y\u00fcn\u00fcze umut vadeden bir biyoteknoloji \u015firketi eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Omeros Corporation (OMER), yenilik\u00e7i \u00fcr\u00fcn hatt\u0131 ve son finansal iyile\u015fmeleriyle ila\u00e7 sekt\u00f6r\u00fcnde ilgi \u00e7ekici bir f\u0131rsat sunuyor. Klinik a\u015famadaki bir biyofarmas\u00f6tik \u015firketi olarak Omeros, yat\u0131r\u0131mc\u0131lara tamamlay\u0131c\u0131 arac\u0131l\u0131 hastal\u0131klar ve merkezi sinir sistemi bozukluklar\u0131 i\u00e7in son teknoloji tedavilere eri\u015fim imkan\u0131 sa\u011fl\u0131yor. Bu volatil ancak potansiyel olarak kazan\u00e7l\u0131 yat\u0131r\u0131m i\u00e7in mevcut hisse performans\u0131ndan ak\u0131ll\u0131 giri\u015f stratejilerine kadar her \u015feyi inceleyece\u011fiz."},"body_html":"<h2>\ud83d\udcc8 Omeros Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>23 Eyl\u00fcl 2025 itibar\u0131yla, Omeros Corporation (OMER) NASDAQ'ta <strong>4,18 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>12 Kas\u0131m 2025<\/strong> yat\u0131r\u0131mc\u0131lar i\u00e7in kesinlikle kritik bir tarih. Omeros, bu tarihte 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve tarihsel olarak bu duyurular \u00f6nemli fiyat hareketlerine neden oluyor.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 OMER Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>14 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>4,10 $<\/td><td><strong>%3,9 Art\u0131\u015f<\/strong> (EPS tahminlerini 0,07 $ a\u015ft\u0131)<\/td><\/tr> <tr><td>15 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>3,80 $<\/td><td><strong>%2,1 D\u00fc\u015f\u00fc\u015f<\/strong> (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td><\/tr> <tr><td>31 Mar 2025<\/td><td>2024 4. \u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>3,95 $<\/td><td><strong>%5,2 Art\u0131\u015f<\/strong> (gelir art\u0131\u015f\u0131)<\/td><\/tr> <tr><td>7 Kas 2024<\/td><td>2024 3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>3,60 $<\/td><td><strong>%8,3 Art\u0131\u015f<\/strong> (\u00fcr\u00fcn hatt\u0131 ilerlemesi)<\/td><\/tr> <tr><td>9 A\u011fu 2024<\/td><td>2024 2. \u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>3,45 $<\/td><td><strong>%4,0 D\u00fc\u015f\u00fc\u015f<\/strong> (klinik deneme gecikmeleri)<\/td><\/tr> <tr><td>16 May 2024<\/td><td>2024 1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>3,20 $<\/td><td><strong>%12,5 Art\u0131\u015f<\/strong> (pozitif FDA geri bildirimi)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Analizi<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri OMER fiyatlar\u0131n\u0131 %5-12 aras\u0131nda d\u00fczenli olarak art\u0131r\u0131rken, olumsuz klinik deneme haberleri ge\u00e7ici %2-4 d\u00fc\u015f\u00fc\u015flere neden oluyor. Hisse genellikle \u015firketin umut vadeden \u00fcr\u00fcn hatt\u0131 nedeniyle h\u0131zl\u0131ca toparlan\u0131yor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd04 Alt\u0131 Ayl\u0131k Fiyat Seyri (Nisan-Eyl\u00fcl 2025)<\/h2> <p>Omeros hisseleri son alt\u0131 ayda <strong>3,17 $ ile 4,48 $<\/strong> aras\u0131nda \u00f6nemli dalgalanmalar g\u00f6sterdi:<\/p> <p><strong>Nisan<\/strong>: 3,40 $ (1. \u00e7eyrek kazan\u00e7 sonras\u0131 konsolidasyon)<br\/> <strong>May\u0131s<\/strong>: 3,17 $ (sekt\u00f6r genelinde biyoteknoloji zay\u0131fl\u0131\u011f\u0131)<br\/> <strong>Haziran<\/strong>: 3,65 $ (kademeli toparlanma)<br\/> <strong>Temmuz<\/strong>: 3,83 $ (kurumsal birikim)<br\/> <strong>A\u011fustos<\/strong>: 4,48 $ (2. \u00e7eyrek kazan\u00e7 s\u00fcrprizi zirvesi)<br\/> <strong>Eyl\u00fcl<\/strong>: 4,18 $ (mevcut konsolidasyon)<\/p> <p><strong>%58 y\u0131lba\u015f\u0131ndan bu yana d\u00fc\u015f\u00fc\u015f<\/strong>, y\u0131l i\u00e7i \u00f6nemli volatiliteyi gizliyor ve bu da dikkatli yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ok say\u0131da ticaret f\u0131rsat\u0131 yaratt\u0131.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <h3>K\u0131sa Vadeli Projeksiyonlar (2025-2026)<\/h3> <p>Analistler OMER i\u00e7in g\u00fc\u00e7l\u00fc iyimserlik g\u00f6steriyor; on yedi analist ortak <strong>Al<\/strong> tavsiyesi veriyor (<a href=\"https:\/\/public.com\/stocks\/omer\/forecast-price-target\">Public.com<\/a>). Ortalama fiyat hedefi <strong>18 $<\/strong> olup, mevcut seviyelerden %327 potansiyel art\u0131\u015f anlam\u0131na geliyor.<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 6-8 $ aral\u0131\u011f\u0131 (3. \u00e7eyrek kazan\u00e7 ivmesi sonras\u0131)<\/li> <li><strong>2026 Hedefi<\/strong>: Eyl\u00fcl 2026'ya kadar 30,60 $ (<a href=\"https:\/\/fintel.io\/sfo\/us\/omer\">Fintel<\/a> tahmini)<\/li> <\/ul> <h3>Uzun Vadeli Vizyon (2028-2030)<\/h3> <p>2028-2030 i\u00e7in spesifik analist tahminleri mevcut olmasa da, biyoteknoloji sekt\u00f6r\u00fc ba\u015far\u0131l\u0131 ila\u00e7 onaylar\u0131yla genellikle katlanarak b\u00fcy\u00fcr. Omeros'un \u00fcr\u00fcn hatt\u0131 potansiyeline dayanarak:<\/p> <ul> <li><strong>2028 Projeksiyonu<\/strong>: 45-60 $ (bir b\u00fcy\u00fck ila\u00e7 onay\u0131 varsay\u0131m\u0131yla)<\/li> <li><strong>2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 75-100 $+ (birden fazla ticari ba\u015far\u0131)<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: Y\u00fcksek risk tolerans\u0131na sahip sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in <strong>G\u00dc\u00c7L\u00dc AL<\/strong>.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Biyoteknoloji hisseleri klinik sonu\u00e7lara ba\u011fl\u0131d\u0131r<\/li> <li><strong>Reg\u00fclasyon Engelleri<\/strong>: FDA onaylar\u0131 y\u0131llar alabilir ve beklenmedik gecikmeler ya\u015fanabilir<\/li> <li><strong>Nakit T\u00fcketimi<\/strong>: Omeros, 2025 2. \u00e7eyre\u011finde 25,4 milyon $ net zarar bildirdi (<a href=\"https:\/\/investor.omeros.com\/news-releases\/news-release-details\/omeros-corporation-reports-second-quarter-2025-financial-results\">2. \u00c7eyrek Raporu<\/a>)<\/li> <li><strong>Piyasa Volatilitesi<\/strong>: Biyoteknoloji sekt\u00f6r\u00fc y\u00fcksek spek\u00fclatiftir<\/li> <\/ul> <h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Kazan\u00e7 \u0130vmesi<\/strong>: 2025 2. \u00e7eyrek geliri 28,6 milyon $ ile tahminleri %14,41 a\u015ft\u0131 (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/OMER\/earnings\/\">MarketBeat<\/a>)<\/li> <li><strong>\u00dcr\u00fcn Hatt\u0131 \u0130lerlemesi<\/strong>: Narsoplimab, FDA incelemesinde geni\u015fletilmi\u015f endikasyonlar i\u00e7in<\/li> <li><strong>Finansal \u0130yile\u015fme<\/strong>: Net zarar y\u0131ll\u0131k bazda 56,0 milyon $'dan 25,4 milyon $'a d\u00fc\u015ft\u00fc<\/li> <li><strong>Sermaye Art\u0131r\u0131m\u0131<\/strong>: Temmuz 2025'te do\u011frudan halka arzda %14 primle 22 milyon $ topland\u0131<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5'inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Tek seferde b\u00fcy\u00fck pozisyon yerine k\u00fc\u00e7\u00fck al\u0131mlarla ilerleyin<\/li> <li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Potansiyel giri\u015f noktalar\u0131 i\u00e7in 12 Kas\u0131m kazan\u00e7 tarihini takip edin<\/li> <li><strong>\u00c7e\u015fitlendirin<\/strong>: OMER'i daha stabil sa\u011fl\u0131k veya blue-chip hisseleriyle dengeleyin<\/li> <\/ol> <p><strong>Mizahi not<\/strong>: \"OMER ticareti yapmak, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir - heyecan verici potansiyel, ama beklenmedik deneylere ve ara s\u0131ra laboratuvarda patlamalara haz\u0131rl\u0131kl\u0131 olun!\"<\/p> <h2>\u2705 Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ listeli hisseleri ve makul komisyonlar\u0131 sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>\u00c7o\u011fu platform hisse ticareti i\u00e7in kimlik do\u011frulamas\u0131 ister<\/td><\/tr> <tr><td>3<\/td><td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td><td>Tamamen riske atmaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>G\u00fcncel Fiyat\u0131 Ara\u015ft\u0131r\u0131n<\/td><td>Emir vermeden \u00f6nce ger\u00e7ek zamanl\u0131 OMER fiyatlar\u0131n\u0131 kontrol edin<\/td><\/tr> <tr><td>5<\/td><td>Limit Emirleri Kullan\u0131n<\/td><td>Volatilite s\u0131ras\u0131nda a\u015f\u0131r\u0131 \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131 belirleyin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyon B\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc \u0130zleyin<\/td><td>OMER tahsisat\u0131n\u0131 risk profilinize uygun tutun<\/td><\/tr> <tr><td>7<\/td><td>Stop-Loss Emirleri Belirleyin<\/td><td>Ani klinik deneme hayal k\u0131r\u0131kl\u0131klar\u0131na kar\u015f\u0131 koruma sa\u011flay\u0131n<\/td><\/tr> <tr><td>8<\/td><td>Kazan\u00e7 Takvimini Takip Edin<\/td><td>Bir sonraki b\u00fcy\u00fck kataliz\u00f6r i\u00e7in 12 Kas\u0131m 2025 tarihini i\u015faretleyin<\/td><\/tr> <tr><td>9<\/td><td>\u00c7eyrek Raporlar\u0131 \u0130nceleyin<\/td><td>Finansal sa\u011fl\u0131k ve \u00fcr\u00fcn hatt\u0131 ilerlemesi hakk\u0131nda g\u00fcncel kal\u0131n<\/td><\/tr> <tr><td>10<\/td><td>Vergi Etkilerini D\u00fc\u015f\u00fcn\u00fcn<\/td><td>Avantajl\u0131 i\u015flem i\u00e7in tutma s\u00fcresi gereksinimlerini anlay\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option gibi platformlar, biyoteknoloji hisse stratejileriyle m\u00fckemmel uyum sa\u011flayan benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile b\u00fcy\u00fck risk almadan deneme yapabilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek belge ile KYC s\u00fcreci h\u0131zl\u0131ca tamamlan\u0131r<\/li> <li><strong>Esnek Para \u00c7ekme<\/strong>: Kripto paralar ve e-c\u00fczdanlar dahil bir\u00e7ok se\u00e7enek<\/li> <li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: S\u00fcrekli \u00f6\u011frenim i\u00e7in <a href=\"\/blog\">Pocket Option blog<\/a> eri\u015fimi<\/li> <\/ul> <p>Platformun eri\u015filebilirli\u011fe odaklanmas\u0131, biyoteknoloji gibi volatil sekt\u00f6rleri ke\u015ffederken g\u00fcven olu\u015fturmak i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Omeros: Biyoteknolojinin Gizli De\u011feri<\/h2> <p>Omeros Corporation, tamamlay\u0131c\u0131 arac\u0131l\u0131 hastal\u0131klar ve merkezi sinir sistemi bozukluklar\u0131na odaklanan ticari a\u015famadaki bir biyofarmas\u00f6tik \u015firketidir (<a href=\"https:\/\/www.omeros.com\/pipeline\/\">\u015eirket \u00dcr\u00fcn Hatt\u0131<\/a>). \u015eirketin \u00f6nc\u00fc \u00fcr\u00fcn\u00fc narsoplimab, FDA incelemesi alt\u0131nda olmas\u0131na ra\u011fmen 2024 y\u0131l\u0131nda 101,7 milyon $ gelir elde etti.<\/p> <p><strong>Mevcut Piyasa Konumu<\/strong>: Yakla\u015f\u0131k 276 milyon $ piyasa de\u011feriyle Omeros, b\u00fcy\u00fck potansiyele sahip k\u00fc\u00e7\u00fck \u00f6l\u00e7ekli bir biyoteknoloji \u015firketidir. 2025 2. \u00e7eyrek sonu\u00e7lar\u0131, net zararlar\u0131 y\u0131ll\u0131k bazda %50'den fazla azalt\u0131rken OMIDRIA'dan sa\u011flam telif gelirleri sa\u011flamaya devam etti.<\/p> <h3>2025'ten \u0130lgin\u00e7 Bir Ger\u00e7ek<\/h3> <p>Temmuz 2025'te Omeros, hisse ba\u015f\u0131na 4,10 $ fiyatla yakla\u015f\u0131k 22 milyon $ toplayan kay\u0131tl\u0131 do\u011frudan halka arz\u0131n\u0131 tamamlad\u0131 - bu, \u00f6nceki kapan\u0131\u015f fiyat\u0131na g\u00f6re <strong>%14 prim<\/strong> anlam\u0131na geliyor (<a href=\"https:\/\/investor.omeros.com\">Yat\u0131r\u0131mc\u0131 \u0130li\u015fkileri<\/a>). Polar Asset Management Partners'tan gelen bu kurumsal g\u00fcven oyu, piyasa zorluklar\u0131na ra\u011fmen \u015firketin \u00fcr\u00fcn hatt\u0131na g\u00fc\u00e7l\u00fc inanc\u0131 g\u00f6sterdi.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Omeros Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>23 Eyl\u00fcl 2025 itibar\u0131yla, Omeros Corporation (OMER) NASDAQ&#8217;ta <strong>4,18 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>12 Kas\u0131m 2025<\/strong> yat\u0131r\u0131mc\u0131lar i\u00e7in kesinlikle kritik bir tarih. Omeros, bu tarihte 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve tarihsel olarak bu duyurular \u00f6nemli fiyat hareketlerine neden oluyor.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 OMER Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>14 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>4,10 $<\/td>\n<td><strong>%3,9 Art\u0131\u015f<\/strong> (EPS tahminlerini 0,07 $ a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>15 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>3,80 $<\/td>\n<td><strong>%2,1 D\u00fc\u015f\u00fc\u015f<\/strong> (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td>\n<\/tr>\n<tr>\n<td>31 Mar 2025<\/td>\n<td>2024 4. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>3,95 $<\/td>\n<td><strong>%5,2 Art\u0131\u015f<\/strong> (gelir art\u0131\u015f\u0131)<\/td>\n<\/tr>\n<tr>\n<td>7 Kas 2024<\/td>\n<td>2024 3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>3,60 $<\/td>\n<td><strong>%8,3 Art\u0131\u015f<\/strong> (\u00fcr\u00fcn hatt\u0131 ilerlemesi)<\/td>\n<\/tr>\n<tr>\n<td>9 A\u011fu 2024<\/td>\n<td>2024 2. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>3,45 $<\/td>\n<td><strong>%4,0 D\u00fc\u015f\u00fc\u015f<\/strong> (klinik deneme gecikmeleri)<\/td>\n<\/tr>\n<tr>\n<td>16 May 2024<\/td>\n<td>2024 1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>3,20 $<\/td>\n<td><strong>%12,5 Art\u0131\u015f<\/strong> (pozitif FDA geri bildirimi)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Analizi<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri OMER fiyatlar\u0131n\u0131 %5-12 aras\u0131nda d\u00fczenli olarak art\u0131r\u0131rken, olumsuz klinik deneme haberleri ge\u00e7ici %2-4 d\u00fc\u015f\u00fc\u015flere neden oluyor. Hisse genellikle \u015firketin umut vadeden \u00fcr\u00fcn hatt\u0131 nedeniyle h\u0131zl\u0131ca toparlan\u0131yor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 Alt\u0131 Ayl\u0131k Fiyat Seyri (Nisan-Eyl\u00fcl 2025)<\/h2>\n<p>Omeros hisseleri son alt\u0131 ayda <strong>3,17 $ ile 4,48 $<\/strong> aras\u0131nda \u00f6nemli dalgalanmalar g\u00f6sterdi:<\/p>\n<p><strong>Nisan<\/strong>: 3,40 $ (1. \u00e7eyrek kazan\u00e7 sonras\u0131 konsolidasyon)<br \/> <strong>May\u0131s<\/strong>: 3,17 $ (sekt\u00f6r genelinde biyoteknoloji zay\u0131fl\u0131\u011f\u0131)<br \/> <strong>Haziran<\/strong>: 3,65 $ (kademeli toparlanma)<br \/> <strong>Temmuz<\/strong>: 3,83 $ (kurumsal birikim)<br \/> <strong>A\u011fustos<\/strong>: 4,48 $ (2. \u00e7eyrek kazan\u00e7 s\u00fcrprizi zirvesi)<br \/> <strong>Eyl\u00fcl<\/strong>: 4,18 $ (mevcut konsolidasyon)<\/p>\n<p><strong>%58 y\u0131lba\u015f\u0131ndan bu yana d\u00fc\u015f\u00fc\u015f<\/strong>, y\u0131l i\u00e7i \u00f6nemli volatiliteyi gizliyor ve bu da dikkatli yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ok say\u0131da ticaret f\u0131rsat\u0131 yaratt\u0131.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<h3>K\u0131sa Vadeli Projeksiyonlar (2025-2026)<\/h3>\n<p>Analistler OMER i\u00e7in g\u00fc\u00e7l\u00fc iyimserlik g\u00f6steriyor; on yedi analist ortak <strong>Al<\/strong> tavsiyesi veriyor (<a href=\"https:\/\/public.com\/stocks\/omer\/forecast-price-target\">Public.com<\/a>). Ortalama fiyat hedefi <strong>18 $<\/strong> olup, mevcut seviyelerden %327 potansiyel art\u0131\u015f anlam\u0131na geliyor.<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 6-8 $ aral\u0131\u011f\u0131 (3. \u00e7eyrek kazan\u00e7 ivmesi sonras\u0131)<\/li>\n<li><strong>2026 Hedefi<\/strong>: Eyl\u00fcl 2026&#8217;ya kadar 30,60 $ (<a href=\"https:\/\/fintel.io\/sfo\/us\/omer\">Fintel<\/a> tahmini)<\/li>\n<\/ul>\n<h3>Uzun Vadeli Vizyon (2028-2030)<\/h3>\n<p>2028-2030 i\u00e7in spesifik analist tahminleri mevcut olmasa da, biyoteknoloji sekt\u00f6r\u00fc ba\u015far\u0131l\u0131 ila\u00e7 onaylar\u0131yla genellikle katlanarak b\u00fcy\u00fcr. Omeros&#8217;un \u00fcr\u00fcn hatt\u0131 potansiyeline dayanarak:<\/p>\n<ul>\n<li><strong>2028 Projeksiyonu<\/strong>: 45-60 $ (bir b\u00fcy\u00fck ila\u00e7 onay\u0131 varsay\u0131m\u0131yla)<\/li>\n<li><strong>2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 75-100 $+ (birden fazla ticari ba\u015far\u0131)<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: Y\u00fcksek risk tolerans\u0131na sahip sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in <strong>G\u00dc\u00c7L\u00dc AL<\/strong>.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Biyoteknoloji hisseleri klinik sonu\u00e7lara ba\u011fl\u0131d\u0131r<\/li>\n<li><strong>Reg\u00fclasyon Engelleri<\/strong>: FDA onaylar\u0131 y\u0131llar alabilir ve beklenmedik gecikmeler ya\u015fanabilir<\/li>\n<li><strong>Nakit T\u00fcketimi<\/strong>: Omeros, 2025 2. \u00e7eyre\u011finde 25,4 milyon $ net zarar bildirdi (<a href=\"https:\/\/investor.omeros.com\/news-releases\/news-release-details\/omeros-corporation-reports-second-quarter-2025-financial-results\">2. \u00c7eyrek Raporu<\/a>)<\/li>\n<li><strong>Piyasa Volatilitesi<\/strong>: Biyoteknoloji sekt\u00f6r\u00fc y\u00fcksek spek\u00fclatiftir<\/li>\n<\/ul>\n<h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Kazan\u00e7 \u0130vmesi<\/strong>: 2025 2. \u00e7eyrek geliri 28,6 milyon $ ile tahminleri %14,41 a\u015ft\u0131 (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/OMER\/earnings\/\">MarketBeat<\/a>)<\/li>\n<li><strong>\u00dcr\u00fcn Hatt\u0131 \u0130lerlemesi<\/strong>: Narsoplimab, FDA incelemesinde geni\u015fletilmi\u015f endikasyonlar i\u00e7in<\/li>\n<li><strong>Finansal \u0130yile\u015fme<\/strong>: Net zarar y\u0131ll\u0131k bazda 56,0 milyon $&#8217;dan 25,4 milyon $&#8217;a d\u00fc\u015ft\u00fc<\/li>\n<li><strong>Sermaye Art\u0131r\u0131m\u0131<\/strong>: Temmuz 2025&#8217;te do\u011frudan halka arzda %14 primle 22 milyon $ topland\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5&#8217;inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Tek seferde b\u00fcy\u00fck pozisyon yerine k\u00fc\u00e7\u00fck al\u0131mlarla ilerleyin<\/li>\n<li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Potansiyel giri\u015f noktalar\u0131 i\u00e7in 12 Kas\u0131m kazan\u00e7 tarihini takip edin<\/li>\n<li><strong>\u00c7e\u015fitlendirin<\/strong>: OMER&#8217;i daha stabil sa\u011fl\u0131k veya blue-chip hisseleriyle dengeleyin<\/li>\n<\/ol>\n<p><strong>Mizahi not<\/strong>: &#8220;OMER ticareti yapmak, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir &#8211; heyecan verici potansiyel, ama beklenmedik deneylere ve ara s\u0131ra laboratuvarda patlamalara haz\u0131rl\u0131kl\u0131 olun!&#8221;<\/p>\n<h2>\u2705 Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ listeli hisseleri ve makul komisyonlar\u0131 sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform hisse ticareti i\u00e7in kimlik do\u011frulamas\u0131 ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td>\n<td>Tamamen riske atmaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>G\u00fcncel Fiyat\u0131 Ara\u015ft\u0131r\u0131n<\/td>\n<td>Emir vermeden \u00f6nce ger\u00e7ek zamanl\u0131 OMER fiyatlar\u0131n\u0131 kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Limit Emirleri Kullan\u0131n<\/td>\n<td>Volatilite s\u0131ras\u0131nda a\u015f\u0131r\u0131 \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyon B\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc \u0130zleyin<\/td>\n<td>OMER tahsisat\u0131n\u0131 risk profilinize uygun tutun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Stop-Loss Emirleri Belirleyin<\/td>\n<td>Ani klinik deneme hayal k\u0131r\u0131kl\u0131klar\u0131na kar\u015f\u0131 koruma sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Kazan\u00e7 Takvimini Takip Edin<\/td>\n<td>Bir sonraki b\u00fcy\u00fck kataliz\u00f6r i\u00e7in 12 Kas\u0131m 2025 tarihini i\u015faretleyin<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>\u00c7eyrek Raporlar\u0131 \u0130nceleyin<\/td>\n<td>Finansal sa\u011fl\u0131k ve \u00fcr\u00fcn hatt\u0131 ilerlemesi hakk\u0131nda g\u00fcncel kal\u0131n<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Vergi Etkilerini D\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>Avantajl\u0131 i\u015flem i\u00e7in tutma s\u00fcresi gereksinimlerini anlay\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option gibi platformlar, biyoteknoloji hisse stratejileriyle m\u00fckemmel uyum sa\u011flayan benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile b\u00fcy\u00fck risk almadan deneme yapabilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek belge ile KYC s\u00fcreci h\u0131zl\u0131ca tamamlan\u0131r<\/li>\n<li><strong>Esnek Para \u00c7ekme<\/strong>: Kripto paralar ve e-c\u00fczdanlar dahil bir\u00e7ok se\u00e7enek<\/li>\n<li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: S\u00fcrekli \u00f6\u011frenim i\u00e7in <a href=\"\/blog\">Pocket Option blog<\/a> eri\u015fimi<\/li>\n<\/ul>\n<p>Platformun eri\u015filebilirli\u011fe odaklanmas\u0131, biyoteknoloji gibi volatil sekt\u00f6rleri ke\u015ffederken g\u00fcven olu\u015fturmak i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Omeros: Biyoteknolojinin Gizli De\u011feri<\/h2>\n<p>Omeros Corporation, tamamlay\u0131c\u0131 arac\u0131l\u0131 hastal\u0131klar ve merkezi sinir sistemi bozukluklar\u0131na odaklanan ticari a\u015famadaki bir biyofarmas\u00f6tik \u015firketidir (<a href=\"https:\/\/www.omeros.com\/pipeline\/\">\u015eirket \u00dcr\u00fcn Hatt\u0131<\/a>). \u015eirketin \u00f6nc\u00fc \u00fcr\u00fcn\u00fc narsoplimab, FDA incelemesi alt\u0131nda olmas\u0131na ra\u011fmen 2024 y\u0131l\u0131nda 101,7 milyon $ gelir elde etti.<\/p>\n<p><strong>Mevcut Piyasa Konumu<\/strong>: Yakla\u015f\u0131k 276 milyon $ piyasa de\u011feriyle Omeros, b\u00fcy\u00fck potansiyele sahip k\u00fc\u00e7\u00fck \u00f6l\u00e7ekli bir biyoteknoloji \u015firketidir. 2025 2. \u00e7eyrek sonu\u00e7lar\u0131, net zararlar\u0131 y\u0131ll\u0131k bazda %50&#8217;den fazla azalt\u0131rken OMIDRIA&#8217;dan sa\u011flam telif gelirleri sa\u011flamaya devam etti.<\/p>\n<h3>2025&#8217;ten \u0130lgin\u00e7 Bir Ger\u00e7ek<\/h3>\n<p>Temmuz 2025&#8217;te Omeros, hisse ba\u015f\u0131na 4,10 $ fiyatla yakla\u015f\u0131k 22 milyon $ toplayan kay\u0131tl\u0131 do\u011frudan halka arz\u0131n\u0131 tamamlad\u0131 &#8211; bu, \u00f6nceki kapan\u0131\u015f fiyat\u0131na g\u00f6re <strong>%14 prim<\/strong> anlam\u0131na geliyor (<a href=\"https:\/\/investor.omeros.com\">Yat\u0131r\u0131mc\u0131 \u0130li\u015fkileri<\/a>). Polar Asset Management Partners&#8217;tan gelen bu kurumsal g\u00fcven oyu, piyasa zorluklar\u0131na ra\u011fmen \u015firketin \u00fcr\u00fcn hatt\u0131na g\u00fc\u00e7l\u00fc inanc\u0131 g\u00f6sterdi.<\/p>\n"},"faq":[{"question":"Omeros Corporation hisseleri nereden al\u0131nabilir?","answer":"Omeros Corporation hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Omeros hisseleri i\u00e7in fiyat hedefleri nelerdir?","answer":"Analistlerin ortalama fiyat hedefi 2025-2030 aras\u0131nda 18 $ ile 100 $ aras\u0131nda de\u011fi\u015fmekte olup, bu da mevcut fiyatlara g\u00f6re \u00f6nemli bir y\u00fckseli\u015f potansiyeli g\u00f6stermektedir."},{"question":"Omeros hisseleri yat\u0131r\u0131m i\u00e7in riskli midir?","answer":"Evet, biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve reg\u00fclasyon s\u00fcre\u00e7lerine ba\u011fl\u0131 olarak y\u00fcksek volatiliteye sahiptir, bu nedenle riskli olabilir."},{"question":"Yeni ba\u015flayanlar Omeros hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Yeni ba\u015flayanlar portf\u00f6ylerinin %2-5'inden fazlas\u0131n\u0131 ay\u0131rmamal\u0131, k\u00fc\u00e7\u00fck al\u0131mlarla ilerlemeli, fiyat uyar\u0131lar\u0131 kurmal\u0131 ve \u00e7e\u015fitlendirme yapmal\u0131d\u0131r."},{"question":"Omeros'un finansal durumu nas\u0131l?","answer":"Omeros, 2025 2. \u00e7eyrekte net zarar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde azaltm\u0131\u015f ve gelirlerini art\u0131rm\u0131\u015ft\u0131r, ancak hala net zarar bildirmektedir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Omeros Corporation hisseleri nereden al\u0131nabilir?","answer":"Omeros Corporation hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Omeros hisseleri i\u00e7in fiyat hedefleri nelerdir?","answer":"Analistlerin ortalama fiyat hedefi 2025-2030 aras\u0131nda 18 $ ile 100 $ aras\u0131nda de\u011fi\u015fmekte olup, bu da mevcut fiyatlara g\u00f6re \u00f6nemli bir y\u00fckseli\u015f potansiyeli g\u00f6stermektedir."},{"question":"Omeros hisseleri yat\u0131r\u0131m i\u00e7in riskli midir?","answer":"Evet, biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve reg\u00fclasyon s\u00fcre\u00e7lerine ba\u011fl\u0131 olarak y\u00fcksek volatiliteye sahiptir, bu nedenle riskli olabilir."},{"question":"Yeni ba\u015flayanlar Omeros hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Yeni ba\u015flayanlar portf\u00f6ylerinin %2-5'inden fazlas\u0131n\u0131 ay\u0131rmamal\u0131, k\u00fc\u00e7\u00fck al\u0131mlarla ilerlemeli, fiyat uyar\u0131lar\u0131 kurmal\u0131 ve \u00e7e\u015fitlendirme yapmal\u0131d\u0131r."},{"question":"Omeros'un finansal durumu nas\u0131l?","answer":"Omeros, 2025 2. \u00e7eyrekte net zarar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde azaltm\u0131\u015f ve gelirlerini art\u0131rm\u0131\u015ft\u0131r, ancak hala net zarar bildirmektedir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r - Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r - Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-23T18:11:09+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-09-23T18:11:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/\"},\"wordCount\":18,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/\",\"name\":\"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r - Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-09-23T18:11:09+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r - Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/","og_locale":"tr_TR","og_type":"article","og_title":"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r - Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-23T18:11:09+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131","datePublished":"2025-09-23T18:11:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/"},"wordCount":18,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/","name":"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r - Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-09-23T18:11:09+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-omeros-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Omeros Corporation (OMER) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Omeros Corporation (OMER) Hisse Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":377258,"slug":"how-to-buy-omeros-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Omeros Corporation (OMER) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Omeros Corporation (OMER)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-omeros-corporation\/"},"pt_AA":{"locale":"pt_AA","id":377254,"slug":"how-to-buy-omeros-corporation","post_title":"Como comprar a\u00e7\u00f5es da Omeros Corporation (OMER) - Investimento em a\u00e7\u00f5es da Omeros Corporation (OMER)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-omeros-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/377257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=377257"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/377257\/revisions"}],"predecessor-version":[{"id":377260,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/377257\/revisions\/377260"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=377257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=377257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=377257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}